Myasthenia gravis and pregnancy
Recommended Citation
Grover KM, and Sripathi N. Myasthenia Gravis and Pregnancy. Muscle Nerve 2020.
Document Type
Article
Publication Date
9-14-2020
Publication Title
Muscle & nerve
Abstract
Myasthenia gravis (MG) is an autoimmune disorder with bimodal age of presentation, occurring in young women of reproductive age and at an older age in men. Occasionally, MG is diagnosed during pregnancy. Management of MG includes symptomatic treatment with cholinesterase inhibitors and immunosuppressive therapy for controlling the disease activity. Treatment of MG in women of reproductive age, who may be contemplating pregnancy, requires discussion regarding the choice of medication as well as the understanding of risks/adverse effects involved with various treatments. During the peripartum period, it is essential to ensure careful monitoring of the disease state along with the well-being of the mother and fetus and to coordinate neonatal monitoring overseen by a multidisciplinary team comprising a high-risk maternal fetal medicine specialist, a neurologist familiar with these complex issues, and a neonatologist.
PubMed ID
32929722
ePublication
ePub ahead of print
